Based on the reversible nature of epigenetic modifications, compared with genetic mutations, these findings suggest IGFBP-2 is switched off in advanced bladder cancer which eliminates the inhibitory effects of this protein on cell proliferation, invasion and colony formation in cancer development. The gene discussed is IGFBP2; the disease is urinary bladder cancer.